doi:10.48130/vns-0025-0002

[1]

Govers BM, van Huet RAC, Roosing S, Keijser S, Los LI, et al. 2023. The genetics and disease mechanisms of rhegmatogenous retinal detachment. Progress in Retinal and Eye Research 97:101158

doi: 10.1016/j.preteyeres.2022.101158

[2]

Mitry D, Charteris DG, Fleck BW, Campbell H, Singh J. 2010. The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations. British Journal of Ophthalmology 94(6):678−84

doi: 10.1136/bjo.2009.157727

[3]

Ge JY, Teo ZL, Chee ML, Tham YC, Rim TH, et al. 2024. International incidence and temporal trends for rhegmatogenous retinal detachment: a systematic review and meta-analysis. Survey of Ophthalmology 69(3):330−36

doi: 10.1016/j.survophthal.2023.11.005

[4]

Öhman T, Gawriyski L, Miettinen S, Varjosalo M, Loukovaara S. 2021. Molecular pathogenesis of rhegmatogenous retinal detachment. Scientific Reports 11(1):966

doi: 10.1038/s41598-020-80005-w

[5]

Lin JB, Narayanan R, Philippakis E, Yonekawa Y, Apte RS. 2024. Retinal detachment. Nature Reviews Disease Primers 10(1):18

doi: 10.1038/s41572-024-00501-5

[6]

Mitry D, Fleck BW, Wright AF, Campbell H, Charteris DG. 2010. Pathogenesis of rhegmatogenous retinal detachment: predisposing anatomy and cell biology. Retina 30(10):1561−72

doi: 10.1097/IAE.0b013e3181f669e6

[7]

Mason RH, Minaker SA, Marafon SB, Figueiredo N, Hillier RJ, et al. 2022. Retinal displacement following rhegmatogenous retinal detachment: a systematic review and meta-analysis. Survey of Ophthalmology 67(4):950−64

doi: 10.1016/j.survophthal.2022.01.002

[8]

D’Amico DJ. 2008. Primary retinal detachment. New England Journal of Medicine 359(22):2346−54

doi: 10.1056/nejmcp0804591

[9]

Moussa G, Andreatta W, Ch'ng SW, Ziaei H, Jalil A, et al. 2022. Environmental effect of air versus gas tamponade in the management of rhegmatogenous retinal detachment VR surgery: a multicentre study of 3,239 patients. PLoS One 17(1):e0263009

doi: 10.1371/journal.pone.0263009

[10]

Lincoff H, Mardirossian J, Lincoff A, Liggett P, Iwamoto T, et al. 1980. Intravitreal longevity of three perfluorocarbon gases. Archives of Ophthalmology 98(9):1610−11

doi: 10.1001/archopht.1980.01020040462012

[11]

Cekic O, Ohji M. 2000. Intraocular gas tamponades. Seminars in Ophthalmology 15(1):3−14

doi: 10.3109/08820530009037846

[12]

Lee JJ, Kwon HJ, Lee SM, Byon IS, Lee JE, et al. 2020. Duration of room air tamponade after vitrectomy. Japanese Journal of Ophthalmology 64(2):216−22

doi: 10.1007/s10384-020-00714-7

[13]

Kontos A, Tee J, Stuart A, Shalchi Z, Williamson TH. 2017. Duration of intraocular gases following vitreoretinal surgery. Graefe’s Archive for Clinical and Experimental Ophthalmology 255(2):231−36

doi: 10.1007/s00417-016-3438-3

[14]

Mondelo-García C, Bandín-Vilar E, García-Quintanilla L, Castro-Balado A, Del Amo EM, et al. 2021. Current situation and challenges in vitreous substitutes. Macromolecular Bioscience 21(8):e2100066

doi: 10.1002/mabi.202100066

[15]

Thompson JT. 1989. Kinetics of intraocular gases. Disappearance of air, sulfur hexafluoride, and perfluoropropane after pars plana vitrectomy. Archives of Ophthalmology 107(5):687−91

doi: 10.1001/archopht.1989.01070010705031

[16]

Warren A, Wang DW, Lim JI. 2023. Rhegmatogenous retinal detachment surgery: a review. Clinical & Experimental Ophthalmology 51(3):271−79

doi: 10.1111/ceo.14205

[17]

Kokavec J, Min SH, Tan MH, Gilhotra JS, Newland HS, et al. 2016. Biochemical analysis of the living human vitreous. Clinical & Experimental Ophthalmology 44(7):597−609

doi: 10.1111/ceo.12732

[18]

Silva AF, Alves MA, Oliveira MSN. 2017. Rheological behaviour of vitreous humour. Rheologica Acta 56:377−86

doi: 10.1007/s00397-017-0997-0

[19]

Gao QY, Fu Y, Hui YN. 2015. Vitreous substitutes: challenges and directions. International Journal of Ophthalmology 8(3):437−40

doi: 10.3980/j.issn.2222-3959.2015.03.01

[20]

Su X, Tan MJ, Li Z, Wong M, Rajamani L, et al. 2015. Recent progress in using biomaterials as vitreous substitutes. Biomacromolecules 16(10):3093−102

doi: 10.1021/acs.biomac.5b01091

[21]

Raia NR, Jia D, Ghezzi CE, Muthukumar M, Kaplan DL. 2020. Characterization of silk-hyaluronic acid composite hydrogels towards vitreous humor substitutes. Biomaterials 233:119729

doi: 10.1016/j.biomaterials.2019.119729

[22]

Donati S, Caprani SM, Airaghi G, Vinciguerra R, Bartalena L, et al. 2014. Vitreous substitutes: the present and the future. BioMed Research International 2014:351804

doi: 10.1155/2014/351804

[23]

Davidović S, Živković M, Risimić D, Rapajić M, Teodorović S, et al. 2023. Macular parameters change during silicon oil tamponade for retinal detachment surgery. Medicina 59(2):334

doi: 10.3390/medicina59020334

[24]

Framme C, Klotz S, Wolf-Schnurrbusch UEK, Wiedemann P, Wolf S. 2012. Intraocular pressure changes following 20G pars-plana vitrectomy. Acta Ophthalmologica 90(8):744−49

doi: 10.1111/j.1755-3768.2011.02251.x

[25]

Wang T, Ran R, Ma Y, Zhang M. 2021. Polymeric hydrogel as a vitreous substitute: current research, challenges, and future directions. Biomedical Materials 16(4):042012

doi: 10.1088/1748-605x/ac058e

[26]

Ohm J. 1911. Über die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flüssigkeit und Einspritzung von Luft in den Glaskörper. Albrecht Von Graefes Archiv Für Ophthalmologie 79:442−50

doi: 10.1007/BF01977971

[27]

Neffendorf JE, Gupta B, Williamson TH. 2018. The role of intraocular gas tamponade in rhegmatogenous retinal detachment: a synthesis of the literature. Retina 38:S65−S72

doi: 10.1097/IAE.0000000000002015

[28]

Idrees S, Sridhar J, Kuriyan AE. 2019. Proliferative Vitreoretinopathy: A Review. International Ophthalmology Clinics 59(1):221−240

doi: 10.1097/IIO.0000000000000258

[29]

Barbosa GCS, Silva AGD, Daher Gonçalves Monteiro dos Reis G, Bermudes FH, Lemos CMB, et al. 2022. Large inferior retinectomies for proliferative vitreoretinopathy in silicone oil-filled eyes. International Journal of Retina and Vitreous 8:73

doi: 10.1186/s40942-022-00420-1

[30]

Charteris DG, Sethi CS, Lewis GP, Fisher SK. 2002. Proliferative vitreoretinopathy—developments in adjunctive treatment and retinal pathology. Eye 16(4):369−374

doi: 10.1038/sj.eye.6700194

[31]

Zhu C, Cheng Y, Tang Y, Wu H, Liu Z. 2024. Changes of aqueous humor cytokine profiles of patients with high intraocular pressure after PPV for retinal detachment. Scientific Reports 14(1):13044

doi: 10.1038/s41598-024-61913-7

[32]

Elizabeth Fini M, Schwartz SG, Gao X, Jeong S, Patel N, et al. 2017. Steroid-induced ocular hypertension/glaucoma: focus on pharmacogenomics and implications for precision medicine. Progress in Retinal and Eye Research 56:58−83

doi: 10.1016/j.preteyeres.2016.09.003